Shield Therapeutics plc carries a market capitalization of 79.06M, placing it among publicly traded companies globally.
| Market Cap | 79.06M |
| Enterprise Value | N/A |
Shield Therapeutics plc's stock has declined approximately -24.51282% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.51282% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.11 |
| Average Volume (20 Days) | N/A |
Shield Therapeutics plc's most recent stock split took place on December 28, 2022 with a 1000:1029 split ratio.
| Last Split Date | 12/28/2022 |
| Split Ratio | 1000:1029 |
Already premium?